Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
Novanta's Capital Expenditure for the
three
months ended in Dec. 2023 was $-6.22 Mil. Its Revenue for the
three
months ended in Dec. 2023 was $211.57 Mil.
Hence, Novanta's Capex-to-Revenue for the
three
months ended in Dec. 2023 was 0.03.
Novanta Capex-to-Revenue Historical Data
The historical data trend for Novanta's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Novanta's Capex-to-Revenue
For the Scientific & Technical Instruments subindustry, Novanta's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novanta's Capex-to-Revenue Distribution in the Hardware Industry
For the Hardware industry and Technology sector, Novanta's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where Novanta's Capex-to-Revenue falls into.
Novanta Capex-to-Revenue Calculation
Novanta's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novanta (NAS:NOVT) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Novanta Capex-to-Revenue Related Terms
Thank you for viewing the detailed overview of Novanta's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: photonics, vision, and precision motion. The photonics segment, which sells photonics-based products that include carbon dioxide lasers, laser scanning, super-resolution imaging lasers, and laser beam delivery items. The vision segment sells medical-grade technologies, including visualization solutions, imaging informatics products, and thermal printers contributing the majority of revenue. The precision motion segment sells optical encoders, motion control technology, and precision machined components. The firm generates the majority of its revenue from the United States and Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NOVT has been successfully added to your 